SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-016737
Filing Date
2024-02-26
Accepted
2024-02-26 09:00:10
Documents
18
Period of Report
2024-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200697-8k_moonlake.htm   iXBRL 8-K 24742
2 PRESS RELEASE, DATED FEBRUARY 26, 2024 ea0200697ex99-1_moonlake.htm EX-99.1 25947
3 GRAPHIC image_001.jpg GRAPHIC 3189
4 GRAPHIC ex99-1_001.jpg GRAPHIC 11326
5 GRAPHIC ex99-1_002.jpg GRAPHIC 6222
  Complete submission text file 0001213900-24-016737.txt   263641

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mltx-20240226.xsd EX-101.SCH 3021
7 XBRL LABEL FILE mltx-20240226_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE mltx-20240226_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0200697-8k_moonlake_htm.xml XML 3485
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 24673772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)